Filing Details
- Accession Number:
- 0001209191-18-010146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-14 18:23:37
- Reporting Period:
- 2018-02-12
- Accepted Time:
- 2018-02-14 18:23:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-12 | 4,500 | $149.22 | 59,958 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 3,200 | $150.44 | 56,758 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 7,296 | $151.22 | 49,462 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 1,100 | $152.26 | 48,362 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 1,400 | $153.25 | 46,962 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 300 | $153.92 | 46,662 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 882 | Indirect | 401(k) |
| Common Stock | 12,215 | Indirect | Held in Trust |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.75).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.81 to $150.76).
- Open market sales reported on this line occurred at a weighted average price of $151.22 (range $150.81 to $151.79).
- Open market sales reported on this line occurred at a weighted average price of $152.26 (range $151.83 to $152.81).
- Open market sales reported on this line occurred at a weighted average price of $153.25 (range $152.87 to $153.82).
- Open market sales reported on this line occurred at a weighted average price of $153.92 (range $153.89 to $153.99).
Billionaire Hedge Funds
